PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1720043
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1720043
Electroencephalography Systems Market size was valued at US$ 1,540.32 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.
Electroencephalography (EEG) systems are medical devices designed to measure and record the brain's electrical activity. By placing electrodes on the scalp, these systems detect and capture the electrical impulses generated by neurons as they communicate. The signals are then amplified and recorded as brainwave patterns, which can be analyzed to assess neurological function. EEG is widely used in clinical settings for diagnosing conditions such as sleep disorders, epilepsy, and brain injuries. It is also employed in research to study brain activity in response to stimuli, cognitive tasks, and mental health conditions like anxiety and depression. One of EEG's key advantages over imaging techniques like MRI or CT scans is its ability to provide real-time data with high temporal resolution. A typical EEG system consists of electrodes, amplifiers, and software for signal processing and analysis. Recent advancements have led to the development of portable and wearable EEG devices, enabling continuous brain activity monitoring outside clinical settings. These innovations have expanded EEG applications to mental health tracking, cognitive training, and brain-computer interface (BCI) systems.
Electroencephalography Systems Market- Market Dynamics
Increasing incidence of neurological disorders, increasing healthcare spending, and greater awareness of the importance of early diagnosis and treatment of brain-related conditions to propel market demand
The global EEG industry is witnessing significant growth, driven by the rising incidence of neurological disorders, increasing healthcare spending, and greater awareness of the importance of early diagnosis and treatment of brain-related conditions. Additionally, supportive government initiatives, regulatory policies, and continuous technological advancements are facilitating regional market expansion, enabling the industry to address diverse healthcare demands across different regions. The growing geriatric population and increasing awareness of the importance of early diagnosis for neurological conditions are key drivers of market growth. For example, in March 2024, researchers at Western University developed a noninvasive technique to improve perfusion analysis across hippocampus sections. This innovation aids in diagnosing neurological disorders such as epilepsy, Alzheimer's, and schizophrenia, supporting healthy aging and reinforcing the demand for EEG devices. Brain health is closely linked to cardiovascular function. Although the brain accounts for only 2% of body weight, it consumes 20% of the body's oxygen and energy resources. Proper heart function ensures sufficient blood flow to the brain, while healthy blood vessels facilitate the delivery of essential oxygen and nutrients, which are critical for normal brain activity. According to the Alzheimer's Association, approximately 12.7 million individuals aged 65 and older will be diagnosed with Alzheimer's disease by 2050. Additionally, the Centers for Disease Control and Prevention (CDC) reports that stroke was the fifth leading cause of death in the U.S. These rising neurological and cerebrovascular disease rates highlight the growing need for continuous monitoring and treatment, further driving demand for EEG systems.
Electroencephalography Systems Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)
Based on product type segmentation, 32-channel EEG segment was predicted to show maximum market share in the year 2024
Based on application segmentation, Trauma & Surgery was the leading application in 2024
Based on Device Type segmentation, standalone EEG devices was the leading Device Type in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Electroencephalography Systems Market is segmented on the basis of Product Type, Application, Device Type, End Use, and Region.
The market is divided into six categories based on product type: 8-channel EEG, 21-channel EEG, 25-channel EEG, 32-channel EEG, 40-channel EEG and Multichannel EEG. The 32-channel EEG segment held the largest market share in 2024, driven by its superior diagnostic capabilities and higher spatial resolution. The growing demand for EEG systems with expanded channel capacity reflects healthcare providers' need for more detailed insights into brain activity. Advancements in technology have made these systems more accessible and user-friendly, further accelerating adoption. For example, in February 2024, Neurotechnology introduced enhanced BrainAccess EEG solutions featuring upgraded headwear, expanded software functionalities, and a new 32-channel system, enabling simultaneous monitoring of multiple brain regions for more precise cognitive and neurological assessments.
The market is divided into three categories based on device type: Multichannel EEG, Standalone Devices, Portable Devices and Wearable Devices. The standalone EEG devices segment led the market in 2024, benefiting from its ability to function independently without additional equipment or connections. These devices offer convenience and portability, making them ideal for clinics, hospitals, and research laboratories. The rising demand for point-of-care diagnostics and remote patient monitoring has fueled adoption, while continuous technological advancements have improved their performance and reliability, driving market growth.
Electroencephalography Systems Market- Geographical Insights
The market is divided into five regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America dominated the electroencephalography (EEG) devices market in 2024, primarily due to the increasing prevalence of sleep disorders and neurodegenerative conditions, coupled with improved insurance coverage. The region's advanced healthcare infrastructure and strong distribution networks of leading vendors further support growth. In the U.S., favorable reimbursement policies have encouraged EEG system adoption for neurological disorder diagnosis. Additionally, government agencies such as the National Institute of Neurological Disorders and Stroke (NINDS) continue to fund R&D efforts in brain and nervous system disorders, reinforcing North America's market leadership.
The EEG devices industry is driven by continuous innovation, stringent regulatory frameworks, and increasing mergers and acquisitions. Regulatory agencies such as the U.S. FDA and the European Medicines Agency (EMA) play a vital role in ensuring product safety, influencing market entry barriers, competitive dynamics, and pricing strategies. The industry is also witnessing a rise in mergers and acquisitions as companies invest in research and development to introduce advanced solutions that meet evolving healthcare needs. Additionally, the demand for wearable EEG-like devices is growing, particularly for brain health monitoring in consumer and clinical applications. For instance, in September 2023, Marcello Massimini from the University of Milan developed a method integrating Transcranial Stimulation (TMS) with EEG to assess consciousness in coma patients using the Perturbational Complexity Index (PCI). A prototype was tested in Milan, and with support from the Tiny Blue Dot Foundation, TMS-EEG devices were distributed to major U.S. neurological hospitals. A spinoff company was established to facilitate clinical adoption, and Massimini received an Innovation Award at the final HBP Summit 2023 in Marseille.
In February 2024, Thyrocare, backed by Pharmeasy, planned to acquire Think Health Diagnostics in Chennai to expand into at-home ECG testing. In March 2022, Interaxon, Inc. (Muse) introduced a VR Software Development Kit (SDK) featuring an EEG-compatible headband for use with leading VR Head-Mounted Displays (HMDs). This innovation, based on the Muse S EEG meditation and sleep headband End Use, highlights the growing integration of biosensing End Use into AR and VR applications for brain health research and monitoring.